Literature DB >> 28123242

CD44 positive/CD24 negative (stem cell like property) breast carcinoma cells as marker of tumor aggression.

Arijit Sen1, B S Sunita2.   

Abstract

BACKGROUND: Cells with stem cell like properties in solid organ malignancies like breast and pancreas have been studied over the last decade and have been found to be associated with poor prognosis. Presence of CD44 positive and CD24 negative tumor cells in breast carcinoma (cells with 'stem cell' like property) as marker of aggressiveness and poor prognosis was checked for association with various markers of disease aggression like age at presentation, size of tumor, histological grade of tumor, triple negative status, level of micro-vessel density, and nodal status.
METHODS: Single and double staining immunohistochemistry protocol was used for CD24 and CD44 staining. The staining protocol was repeated with more contemporary techniques using fluorescent chromogen also.
RESULTS: 52 cases, all females who underwent modified radical mastectomy at a tertiary care hospital over a period of 3 years, were evaluated. No association was found between presence of stem cells and size of lesion, histological grade, triple negative status or micro-vessel density. However, significant association was found with respect to younger age of presentation (p value = 0.044). 20 out of 25 cases with nodal metastasis were positive for presence of stem cells (p value is 0.0003). Further, 18 of these 20 cases also had stem cells in the metastatic nodule. Fluorescent chromogens (FITC and Cyanine Red) revealed similar results.
CONCLUSION: Cases positive for stem cells showed earlier onset of disease and proneness to nodal metastasis.

Entities:  

Keywords:  Breast carcinoma; CD44+/CD24−; Stem cell; Tumor aggression

Year:  2016        PMID: 28123242      PMCID: PMC5221395          DOI: 10.1016/j.mjafi.2016.02.010

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  17 in total

1.  Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.

Authors:  Hee Jeong Kim; Mi-Jung Kim; Sei Hyun Ahn; Byung Ho Son; Sung Bae Kim; Jin Hee Ahn; Woo Chul Noh; Gyungyub Gong
Journal:  Breast       Date:  2011-02       Impact factor: 4.380

2.  Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.

Authors:  Masaya Kai; Hideya Onishi; Masae Souzaki; Haruo Tanaka; Makoto Kubo; Masao Tanaka; Mitsuo Katano
Journal:  Cancer Sci       Date:  2011-09-14       Impact factor: 6.716

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

Review 5.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

6.  Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.

Authors:  Margaret J Currie; Brooke E Beardsley; Gavin C Harris; Sarah P Gunningham; Gabi U Dachs; Birgit Dijkstra; Helen R Morrin; J Elisabeth Wells; Bridget A Robinson
Journal:  Hum Pathol       Date:  2012-10-01       Impact factor: 3.466

7.  The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene.

Authors:  F A Spring; R Dalchau; G L Daniels; G Mallinson; P A Judson; S F Parsons; J W Fabre; D J Anstee
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

8.  Mapping of CD24 and homologous sequences to multiple chromosomal loci.

Authors:  M R Hough; P M Rosten; T L Sexton; R Kay; R K Humphries
Journal:  Genomics       Date:  1994-07-01       Impact factor: 5.736

9.  CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.

Authors:  Yan Lin; Ying Zhong; Heng Guan; Xiaohui Zhang; Qiang Sun
Journal:  J Exp Clin Cancer Res       Date:  2012-07-04

10.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.

Authors:  Carol Sheridan; Hiromitsu Kishimoto; Robyn K Fuchs; Sanjana Mehrotra; Poornima Bhat-Nakshatri; Charles H Turner; Robert Goulet; Sunil Badve; Harikrishna Nakshatri
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.